Cargando…

Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis

Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Kensuke, Asai, Yusuke, Akiyama, Takayuki, Tsuzuki, Shinya, Matsunaga, Nobuaki, Suzuki, Setsuko, Iwamoto, Noriko, Funaki, Takanori, Miyairi, Isao, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259089/
https://www.ncbi.nlm.nih.gov/pubmed/37315843
http://dx.doi.org/10.1016/j.jiac.2023.06.006
_version_ 1785057594033831936
author Shoji, Kensuke
Asai, Yusuke
Akiyama, Takayuki
Tsuzuki, Shinya
Matsunaga, Nobuaki
Suzuki, Setsuko
Iwamoto, Noriko
Funaki, Takanori
Miyairi, Isao
Ohmagari, Norio
author_facet Shoji, Kensuke
Asai, Yusuke
Akiyama, Takayuki
Tsuzuki, Shinya
Matsunaga, Nobuaki
Suzuki, Setsuko
Iwamoto, Noriko
Funaki, Takanori
Miyairi, Isao
Ohmagari, Norio
author_sort Shoji, Kensuke
collection PubMed
description Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not statistically different (86.7% vs 73.3%, P = 0.333).
format Online
Article
Text
id pubmed-10259089
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-102590892023-06-12 Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis Shoji, Kensuke Asai, Yusuke Akiyama, Takayuki Tsuzuki, Shinya Matsunaga, Nobuaki Suzuki, Setsuko Iwamoto, Noriko Funaki, Takanori Miyairi, Isao Ohmagari, Norio J Infect Chemother Note Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not statistically different (86.7% vs 73.3%, P = 0.333). Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. 2023-06-12 /pmc/articles/PMC10259089/ /pubmed/37315843 http://dx.doi.org/10.1016/j.jiac.2023.06.006 Text en © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Note
Shoji, Kensuke
Asai, Yusuke
Akiyama, Takayuki
Tsuzuki, Shinya
Matsunaga, Nobuaki
Suzuki, Setsuko
Iwamoto, Noriko
Funaki, Takanori
Miyairi, Isao
Ohmagari, Norio
Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
title Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
title_full Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
title_fullStr Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
title_full_unstemmed Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
title_short Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
title_sort clinical efficacy of remdesivir for covid-19 in children: a propensity-score-matched analysis
topic Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259089/
https://www.ncbi.nlm.nih.gov/pubmed/37315843
http://dx.doi.org/10.1016/j.jiac.2023.06.006
work_keys_str_mv AT shojikensuke clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT asaiyusuke clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT akiyamatakayuki clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT tsuzukishinya clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT matsunaganobuaki clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT suzukisetsuko clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT iwamotonoriko clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT funakitakanori clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT miyairiisao clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis
AT ohmagarinorio clinicalefficacyofremdesivirforcovid19inchildrenapropensityscorematchedanalysis